| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000022469 |
| Receipt No. | R000025892 |
| Official scientific title of the study | The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies. |
| Date of disclosure of the study information | 2016/06/27 |
| Last modified on | 2017/02/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies. | |
| Title of the study (Brief title) | The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies. | |
| Region |
|
|
| Condition | ||
| Condition | Cardiovascular diseases | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to elucidate appropriate strategies of antithrombotic therapies in patients with atrial fibrillation and other cardiovascular diseases. To do this, we will retrospectively evaluate both thromboembolic and bleeding events associated with antithrombotic therapies in patients enrolled in the Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2) study (NCT00418041, UMIN000000562). Also, the result will be compared with other large-scale cohort studies conducted in Japan. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Thromboembolic and bleeding events associated with antithrombotic therapies |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Atrial fibrillation/atrial flutter, and other cardiovascular diseases | |||
| Key exclusion criteria | Not applicable | |||
| Target sample size | 33700 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Shimokawa |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan |
| TEL | +81-22-717-7153 |
| shimo@cardio.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Yasuhiko Sakata |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan |
| TEL | +81-22-717-7153 |
| Homepage URL | |
| sakatayk@cardio.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine / Tohoku Heart Failure Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Under analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025892 |